Biotechnology(IN20211.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
Biotechnology
IN20211.HK
News
View More

Hong Kong Stock Market Intraday | Hang Seng Index fluctuates, technology chips are all active, Hua Hong Semiconductor rises 9.623%, leading the sector

The main indices of the Hong Kong stock market experienced fluctuations and adjustments during the trading session, with the Hang Seng Index, Hang Seng Tech Index, and the National Enterprises Index all failing to break through their recent highs. The semiconductor technology manufacturing sector performed outstandingly, with Hua Hong Semiconductor soaring by 9.623% and SMIC rising by 5.038%. The technology and internet sector saw fluctuations and adjustments, with Alibaba -W and Tencent Holdings increasing by 4.412% and 3.84%, respectively. The market is focused on economic data and fluctuations in the RMB exchange rate, with a clear preference for structural funds. Popular stocks such as HAO TIAN INTL and Dongyao Pharmaceutical surged strongly, showing signs of sector rotation and theme-driven effects

Market Heartbeat·
HK
01875
+67.60%
HK
09961
-19.23%
Market Heartbeat·
HK
01875
+67.60%
HK
09961
-19.23%

High Growth Tech Stocks In Asia To Watch January 2026

As of January 2026, Asian tech markets are thriving, driven by optimism in domestic innovations. Key high-growth tech companies include Suzhou TFC Optical Communication, CARsgen Therapeutics Holdings, and Beijing Infosec Technologies, which has shown a remarkable turnaround in profitability and revenue growth. Guangdong Fenghua Advanced Technology and Digiwin are also notable for their strategic governance changes and solid growth forecasts. These companies exemplify the potential for investment in Asia's tech sector, reflecting strong innovation and adaptability to market conditions.

Simplywall·
HK
02171
+2.05%
Simplywall·
HK
02171
+2.05%

Hong Kong Stock Midday Review | Three Major Indices All Decline, Travel and Tourism Star Leader Trip.com Plummets 19.65%, Technology Sector Also Under Pressure

As of noon, all three major indices of the Hong Kong stock market have retreated, with the Hang Seng Index down 0.55%, and the Hang Seng Tech Index falling by 1.83%, showing increased divergence among sectors. The retail and internet content sectors continue to be weak, while there is significant divergence in the hotel and cultural tourism sectors, with core leaders such as Trip.com and Alibaba experiencing substantial declines. Funds are focusing on the declining sectors and related leading stocks, while macroeconomic uncertainties are increasing market volatility, leading investors to pay close attention to policy trends and industry fundamentals

Market Heartbeat·
HK
09961
-19.23%
HK
01875
+67.60%
Market Heartbeat·
HK
09961
-19.23%
HK
01875
+67.60%

Brief News: WUXI XDC issues profit warning, expects last year's profit to increase by 38%

WUXI XDC Biotechnology Co., Ltd. expects a 45% year-on-year increase in total revenue for the full year of 2025, with a net profit growth of 38%, mainly due to optimized product and service profit margins and effective cost control. The company also proposed to acquire Voyah at HKD 4 per share, totaling approximately HKD 2.79 billion, with the acquisition price being 60% higher than before the suspension of trading. WUXI XDC's stock price fell 2.3% to HKD 74, while Voyah's stock price surged 58.8% to HKD 3.97

BambooWorks·
HK
02268
-3.76%
HK
01875
+67.60%
BambooWorks·
HK
02268
-3.76%
HK
01875
+67.60%

CITIC International raised the target price of RemeGen to 136 yuan and adjusted the revenue forecast for this year and next year

China Merchants Jinling International released a research report, raising the target price for RemeGen to 136 yuan and adjusting the revenue forecast for 2026 to 2027. RemeGen has reached an exclusive licensing agreement with AbbVie, granting AbbVie the rights to develop, produce, and commercialize RC148 outside of Greater China. RemeGen will receive an upfront payment of $650 million and up to $4.95 billion in milestone payments. The firm believes this transaction has limited short-term impact on KANGFANG and SANSHENG

AASTOCKS·
SH
688331
+1.51%
HK
09995
+1.18%
AASTOCKS·
SH
688331
+1.51%
HK
09995
+1.18%
Posts
View More

$GENFLEET-B(02595.HK) The recent Longbridge lottery rate is acceptable 😌

  • 0

$Beigene(ONC.US)$Zai Lab(ZLAB.US)Trump administration plans to impose strict controls on Chinese pharmaceuticals

mp.weixin.qq.com/s/gihUP-...

$INNOGEN-B(02591.HK) Everyone draws lots...

© 2026 Longbridge｜Disclaimer